Nicholas Cross
Chairman at Accession Therapeutics Limited
Network origin in Nicholas Cross first degree
Entity | Entity type | Industry | |
---|---|---|---|
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK
13
| Extinct | Pharmaceuticals: Major | 13 |
Accession Therapeutics Limited
Accession Therapeutics Limited BiotechnologyHealth Technology Accession Therapeutics Limited is a British biotech company that is developing novel immuno-oncology therapeutics to eradicate cancers by harnessing the immune system more powerfully than ever before. The company is based in Oxford, UK and was founded in 2020 by Bent K. Jakobsen, who has been the CEO since then. The company's product, Trocept, is the first approach that meets the three requirements of being highly specific, broad in action to kill all cancer cell variants present, and potent in activating the full immune system arsenal local to the tumour. The team is built around successful biotech entrepreneurs experienced in taking projects through to the clinic and is supported by a Board comprising experienced international healthcare investors.
3
| Holding Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nicholas Cross via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
ORTHOFIX MEDICAL INC. | Medical Specialties | Director/Board Member | |
STRATA SKIN SCIENCES, INC. | Medical Specialties | Director/Board Member | |
Phoqus Pharmaceuticals Plc
Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Axellis, Inc.
Axellis, Inc. Medical DistributorsDistribution Services Axellis, Inc. sells and distributes medical devices. Its products are used for oncology and cardiology. The company was founded in August 2007 and is headquartered in London, UK | Medical Distributors | Director/Board Member | |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member Founder | |
GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
MEDIGENE AG | Biotechnology | Director/Board Member | |
University of Oxford | College/University | Undergraduate Degree Graduate Degree Corporate Officer/Principal | |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
University of Leeds | College/University | Doctorate Degree | |
OREXO AB | Pharmaceuticals: Major | Chairman | |
Norwegian School of Economics & Business Administration | College/University | Graduate Degree | |
Academy of Medical Sciences
Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Miscellaneous Commercial Services | President | |
Oxfordshire Biotechnet Ltd.
Oxfordshire Biotechnet Ltd. Investment ManagersFinance Oxfordshire Biotechnet Ltd. is a venture capital fund. | Investment Managers | Director/Board Member | |
Heptares Therapeutics Ltd.
Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Founder Founder Founder | |
The Institute of Molecular Medicine | Corporate Officer/Principal | ||
Biotecnol-Serviços e Desenvolvimento SA
Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Miscellaneous Commercial Services | Director/Board Member | |
Northland Capital Partners Ltd.
Northland Capital Partners Ltd. Investment Banks/BrokersFinance Northland Capital Partners Ltd. provides investment banking services. The private company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 1991. Robert Alan Johnson has been the CEO of the company since 2010. | Investment Banks/Brokers | Director/Board Member | |
The Jenner Institute Laboratories
The Jenner Institute Laboratories Miscellaneous Commercial ServicesCommercial Services The Jenner Institute Laboratories engages in the development of vaccine against major diseases. The company was founded in November 2005 and is headquartered in Oxford, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Pharmaceuticals: Major | Chairman | |
The Wellcome Trust Centre for Human Genetics | Founder | ||
Oxford Centre for Diabetes Endocrinology & Metabolism | Corporate Officer/Principal | ||
Birk Venture AS
Birk Venture AS Investment ManagersFinance Birk Venture AS (Birk Venture) is an independent Scandinavian venture capital firm which was founded in 2010 by Hans Ivar Robinson. Based in Oslo, Norway, the firm focuses exclusively on the life science industry, utilizing their industry experience and international network to partner with young companies with significant growth prospects. | Investment Managers | Chief Executive Officer | |
Oxford University Hospitals NHS Trust | Investment Trusts/Mutual Funds | Director/Board Member | |
The Gray Laboratory Cancer Research Trust | Director/Board Member | ||
Biotecnol Ltd.
Biotecnol Ltd. BiotechnologyHealth Technology Biotecnol Ltd. engages in research & development of immuno-oncology antibody products. It specializes in recombinant antibodies, T cell engaging, multispecific antibodies and oncology. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Zelluna Immunotherapy AS
Zelluna Immunotherapy AS BiotechnologyHealth Technology Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member Founder | |
Pneumagen Ltd.
Pneumagen Ltd. BiotechnologyHealth Technology Pneumagen Ltd. is engaged in biotechnology services. The company was founded in 2016 and is headquartered in Fife, the United Kingdom. | Biotechnology | Chairman | |
LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
Kleinwort Benson Ltd. (New York) | Director/Board Member | ||
Trimunocor Ltd.
Trimunocor Ltd. Miscellaneous Commercial ServicesCommercial Services Trimunocor Ltd. is a private company based in Harpenden, UK that focuses on developing ground-breaking solutions to protect premature neonates from chronic lung disease. Trimunocor is a spin-out based on IP from the Medical Research Council and University of Southampton. The British company's website provides information about their solution and their focus, as well as news and events. Visitors can also subscribe to stay up to date with the latest developments. The company was founded by Neill Moray MacKenzie and Howard Clark, with Neill Moray MacKenzie serving as CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
Sutura Therapeutics Ltd.
Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chairman | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Founder Founder Chairman | |
Engimmune Therapeutics AG
Engimmune Therapeutics AG Packaged SoftwareTechnology Services Engimmune Therapeutics AG is a developer of off-the-shelf soluble T-cell receptor drugs to treat solid tumors. The company is based in Allschwil, Switzerland. The Swiss company's proprietary platform technologies enable them to engineer stable, multi-specific TCRs that have high affinity for target cancer antigens and trigger a potent and durable anti-cancer T-cell response without causing damage to healthy cells. The company was founded in 2021 as a spin-off of ETH Zurich from technologies developed by Dr. Rodrigo Vazquez-Lombardi and Professor Sai Reddy. Lars Nieba has been the CEO of the company since 2023. | Packaged Software | Chairman | |
Ingenox Therapeutics Ltd.
Ingenox Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Ingenox Therapeutics Ltd. provides cancer treatment services. The private company is based in Oxford, UK. The CEO of the British company is Nick la Thangue. | Hospital/Nursing Management | Chairman | |
Pneumagen (Holdings) Ltd. | Director/Board Member | ||
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Founder Founder Founder |
Statistics
International
United Kingdom | 31 |
United States | 10 |
Norway | 5 |
Switzerland | 3 |
Germany | 2 |
Sectoral
Health Technology | 26 |
Commercial Services | 6 |
Finance | 5 |
Consumer Services | 4 |
Miscellaneous | 3 |
Operational
Director/Board Member | 114 |
Chairman | 31 |
Corporate Officer/Principal | 27 |
Founder | 20 |
Chief Executive Officer | 16 |
Most connected contacts
Insiders | |
---|---|
Frank Armstrong | 41 |
James Noble | 39 |
John Bell | 27 |
Jerry Christopher Benjamin | 15 |
Iain Charles Wilcock | 14 |
Hans Ivar Robinson | 11 |
Bent K. Jakobsen | 8 |
Helena Tayton-Martin | 8 |
Peter Doyle | 7 |
James M. T. Cochrane | 5 |
Russell Smith | 5 |
David McGibney | 5 |
Neill Moray MacKenzie | 4 |
Nick Cross | 1 |
Ian Kimber | 1 |
- Stock Market
- Insiders
- Nicholas Cross
- Company connections